Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Pollen Group is a venture capital firm founded in 2020, with offices in Jerusalem and Tel Aviv-Yafo, Israel. The firm focuses on impact investments in sectors like climate, healthcare, and biotechnology. It employs a patient capital strategy, providing long-term support to its portfolio companies.
Pollen Group specializes in pre-seed, seed, and growth equity investments in sustainable technology, healthcare innovation, and biotechnology. The firm adopts a hands-on partnership approach, offering mentorship, networking, and operational expertise to early-stage and growth companies.
Notable companies in Pollen Group's portfolio include KIP Medical, which develops oral care products using the Spilanthes plant; ODE Pharma, focused on innovative treatments for respiratory disorders; and Kenaf Ventures, dedicated to carbon removal and biodegradable insulation alternatives.
Submit your pitch through their website's contact form for consideration.
Yes, Pollen Group often leads investment rounds, particularly in early-stage companies where they can provide significant support and guidance.
Pollen Group is open to follow-on investments, especially for companies that demonstrate strong growth potential and alignment with their impact investment thesis.
The specific size of Pollen Group's current fund is not publicly disclosed, but they focus on making substantial investments in their portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.